ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Richard J. Thurer
Hooshang Bolooki
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thurer, R. J.
Right arrow Articles by Bolooki, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thurer, R. J.
Right arrow Articles by Bolooki, H.

Ann Thorac Surg 1986;42:143-147
© 1986 The Society of Thoracic Surgeons

Articles

Automatic Implantable Cardioverter-Defibrillator: Techniques of Implantation and Results

Richard J. Thurer, M.D.*, Richard M. Luceri, M.D., Hooshang Bolooki, M.D.

Department of Surgery, Division of Thoracic and Cardiovascular Surgery, and the Department of Medicine, Division of Cardiology, University of Miami School of Medicine, Miami, FL

* Address reprint requests to Dr. Thurer, Division of Thoracic and Cardiovascular Surgery (R-114), University of Miami School of Medicine, PO Box 016960, Miami, FL 33101

An initial experience with use of the automatic implantable cardioverter-defibrillator (AICD) is described. Twelve patients received the device. One death has occurred during a mean follow-up of 15 months, and it was due to causes other than arrhythmias. Appropriate device discharge terminating a malignant arrhythmia occurred in 9 patients (75%). The observed survival (92%) far exceeds that to be expected in survivors of sudden death treated by conventional means. There have been no operative deaths. Morbidity has been minimal, although three reoperations were required in 2 patients because of lead dislodgment.

The AICD has been demonstrated to be effective in treating patients at risk for sudden arrhythmic death. It can be employed safely with minimum morbidity using a variety of implantation techniques.




This article has been cited by other articles:


Home page
 Ann. Thorac. Surg.Home page
R. D. Dowling, R. J. Keenan, P. F. Ferson, and R. J. Landreneau
Video-assisted thoracoscopic resection of pulmonary metastases
Ann. Thorac. Surg., September 1, 1993; 56(3): 772 - 775.
[Abstract] [PDF]

Home page
 JAMAHome page
A. S. Manolis, H. Rastegar, and N. A. M. Estes III
Automatic Implantable Cardioverter Defibrillator: Current Status
JAMA, September 8, 1989; 262(10): 1362 - 1368.
[Abstract] [PDF]

Home page
 Ann. Thorac. Surg.Home page
N. Shapira, A. I. Cohen, M. Wish, L. J. Weston, and R. D. Fletcher
Transdiaphragmatic Implantation of the Automatic Implantable Cardioverter Defibrillator
Ann. Thorac. Surg., September 1, 1989; 48(3): 371 - 375.
[Abstract] [PDF]

Home page
 Arch SurgHome page
B. M. Blakeman, D. Wilber, and R. Pifarre
Median Sternotomy for Implantable Cardioverter/Defibrillator
Arch Surg, September 1, 1989; 124(9): 1065 - 1066.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1986 by The Society of Thoracic Surgeons.